Neuroncy

  • About Us
  • Our Vision
  • Contact Us
  • Surgery FAQs
  • Diagnostics FAQs

For Patients

  • Doctors
  • Nurses
  • Physiotherapists
  • Hospitals
  • Diagnostics Centers
  • Ambulance

For Providers

  • Hospitals and Diagnostics
  • Homecare
  • Admin

More

  • Privacy Policy
  • Terms and conditions
  • Refund Policy
  • Shipping
  • Join Us
  • Sitemap
© 2024 Neuroncy Healthcare Private Limited. All Rights Reserved.
Facebook pageLinkedIn pageInstagram pageYouTube pageTwitter page
Neuroncy Healthcare
+91 861-786-8693info@neuroncy.com
24 X 7
Facebook pageLinkedIn pageInstagram pageYouTube pageTwitter page
    Neuroncy Logo
  • Join us
  • HospitalsDiagnosticsHomecareAmbulanceBookmark For Providers
    BlogsJoin us
Hospitals
Diagnostics
Homecare
Ambulance
Blogs
    HomeHospitalDiagnosticsHomecare

    Blogs

    Prostate Cancer: Symptoms, Types, and Key Investigations



    Today, the male population recognizes prostate cancer as one of the most significant medical issues. Prostate cancer is the second-most common cause of cancer death in men. It affects 4% of men in undeveloped countries and 15% in developed countries. 
    Prostate cancers tend to arise within the prostate's peripheral zone, and almost all of them are adenocarcinomas. Metastatic spread to pelvic lymph nodes occurs early, and metastases to bone, mainly the lumbar spine and pelvis, are common. Genetic factors are known to play an important role in prostate cancer. 


    Prostate cancer symptoms: 
    Bone pain 
    Hematuria 
    Hematospermia 
    Erectile dysfunction 
    Low back pain 
    Loss of urinary bladder control 
    Weight loss 
    Anemia 
    Ureter obstruction 
    Measurement of PSA levels in a peripheral blood sample, together with DRE, is the cornerstone of diagnosis. Before a PSA test, men should be given careful counseling about the limitations of the test: namely, a normal level does not exclude prostate cancer. At the same time, a high value does not confirm the diagnosis but will open a discussion about biopsy and possible future treatments with potential side effects. Individuals suspected of having prostate cancer, based on an elevated PSA and abnormal DRE, should undergo transrectal ultrasound-guided prostate biopsies. On biopsy, about 40% of patients with a serum PSA of 4.0–10 ng/mL or higher will have prostate cancer, whereas 25% of patients with a PSA of less than 4 ng/mL may also have prostate cancer. Occasionally, patients undergoing TURP for benign hyperplasia may incidentally find a small tumor focus. Suppose the diagnosis of prostate cancer is confirmed. In that case, staging should be performed by pelvic MRI to assess the presence and extent of local involvement, and an isotopic bone scan should be done to monitor and treat prostate cancer. 
    Our team of the best doctors for prostate cancer in Kolkata has saved many lives. If someone you know has prostate cancer, you can help them by sharing about Neuroncy Healthcare, the best prostate cancer hospital in Kolkata. 


    Prostate cancer by different location: 
    Benign prostatic hyperplasia 
    Granulomatous Prostatitis 
    Transitional cell carcinoma of the prostate 
    Prostatic calculi
    Chronic prostatitis 


    Investigations: 
    PSA (prostate-specific antigen) density 
    PAS velocity 
    Total PSA ratio 
    Age-specific PSA
    DRE test 
    The prostate undergoes a Transrectal Ultrasonography (TRUS) guided biopsy procedure. 
    MRI- abdomen/pelvis/MR Urography 
    Serum alkaline phosphate 
    Bone scan 


    Stage of Prostate Cancer: Prostate carcinoma is classified based on the tumor node metastasis (TNM). 


    T: primary tumor 
    TX Primary tumors cannot be assessed. 
    T0: No evidence of primary tumor 
    T1: A clinically inapparent tumor, not palpable or visible by imaging. 
    The T1a tumor is an incidental histological finding in 5% or less of the resected tissue. 
    T1b tumor incidental histological findings in more than 5% of tissue resected 
    A needle biopsy has identified a T1c tumor. 
    T2 tumor confined within the prostate 
    T2a tumor involves one-half of one lobe or less; 
    T2b tumor involves more than half of one lobe but not both lobes. 
    T2c The tumor involves both lobes. 
    T3 The tumor extends through the prostatic capsule. 
    The tumor extends extracapsularly, either unilaterally or bilaterally, causing microscopic involvement in the bladder neck. 
    The T3b tumor invades the seminal vesicle(s). 
    T4 The tumor either fixes itself or invades adjacent structures other than seminal vesicles, such as the external sphincter, rectum, levator muscles, and/or pelvic wall. 

    N: regional lymph nodes 
    NX Regional lymph nodes cannot be assessed. 
    N0: There is no regional lymph node metastasis. 
    N1 Regional lymph node metastasis 


    M: distant metastasis 
    MX Distant metastasis cannot be assessed. 
    M0 No distant metastasis. 
    M1 Distant metastasis 
    M1a Non-regional lymph node(s) 
    M1b Bone(s) 
    M1c Other site(s) 

    Castration-refractory prostate cancer (CRPC, or HRPC) is an advanced prostate cancer. 
    There are mainly two types of CRPC out there: metastatic CRPC and non-metastatic CRPC. 

    Treatment of prostate cancer depends on the stage of the disease: radical prostatectomy, cryosurgery, hormonal therapy, radiotherapy, chemotherapy, and immunotherapy are effective treatments for prostate cancer. To prevent and cure cancer, plan your chemotherapy in Kolkata at the best price possible. 

    Locate and schedule your MRI abdomen, MRI pelvis test, and the best prostate biopsy in Kolkata.

    InstagramTwitterYouTubeFacebook
    Newer
    Urinary Tract and Genital infections
    View all posts
    Older
    Dialysis: Revolutionizing ESRD & CKD Treatment and the Role of Nutrition